Decision Diagnostics Corp.
DECN · OTC
9/30/2021 | 6/30/2021 | 3/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $107 | $3,564 | $8,198 | $6,381 |
| - Cash | $211 | $216 | $439 | $522 |
| + Debt | $3,238 | $3,142 | $2,921 | $2,817 |
| Enterprise Value | $3,134 | $6,491 | $10,680 | $8,676 |
| Revenue | $519 | $552 | $538 | $522 |
| % Growth | -6.1% | 2.7% | 3.1% | – |
| Gross Profit | $115 | $135 | $108 | $104 |
| % Margin | 22.2% | 24.4% | 20.1% | 20% |
| EBITDA | -$491 | -$237 | -$454 | -$916 |
| % Margin | -94.6% | -43% | -84.4% | -175.5% |
| Net Income | -$555 | -$302 | -$972 | -$6,950 |
| % Margin | -107% | -54.6% | -180.8% | -1,331.9% |
| EPS Diluted | -0.002 | -0.001 | -0.003 | -0.022 |
| % Growth | -100% | 70.4% | 87.7% | – |
| Operating Cash Flow | -$60 | -$518 | -$508 | $13 |
| Capital Expenditures | -$2 | -$30 | -$5 | $0 |
| Free Cash Flow | -$62 | -$548 | -$513 | $13 |